Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Carrick Therapeutics

Carrick Therapeutics
2015 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$95M LATEST DEAL AMOUNT
7 INVESTORS
Description

Developer of cancer therapeutics intended to target molecular pathways that drive the most aggressive and resistant forms of cancer. The company's cancer therapeutics are innovative first-in-class mechanisms, enabling cancer patients to get their predictive biomarkers detected and get their treatments started from the first stage.

Formerly Known As
Navillus Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Therapeutic Devices
Primary Office
  • Belfield Innovation Park
  • University College Dublin, Belfield
  • Dublin 4
  • Ireland
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Carrick Therapeutics’s full profile, request a free trial.

Carrick Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 03-Oct-2016 $95M 0000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Carrick Therapeutics Competitors (24)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aura Biosciences Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
00000000000 Angel-Backed Culver City, CA 00000 000000000000 00000
000000000 Venture Capital-Backed Rockville, MD 000.00 0000000000 0 000.00
0000 000000 Formerly VC-backed Santa Monica, CA 000 00000 000000&0 00000
00000000 Venture Capital-Backed Waltham, MA 0 000.00 00000000000 000.00
To view this company’s complete list of competitors, request access »

Carrick Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
ARCH Venture Partners Venture Capital Minority 000 0000 000000 0
Cambridge Enterprise Venture Capital Minority 000 0000 000000 0
Cambridge Innovation Capital Venture Capital Minority 000 0000 000000 0
Evotec Corporation Minority 000 0000 000000 0
GV Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Carrick Therapeutics Executive Team (4)

Name Title Board
Seat
Contact
Info
Elaine Sullivan Ph.D Co-Founder, Chief Executive Officer & Board Member
Edward Ainscow Ph.D Co-Founder & Head of Discovery
Ash Bahl Co-Founder & Head of Research & Development
George Golumbeski Ph.D Chairman

Carrick Therapeutics Board Members (9)

Name Representing Role Since Contact
Info
Burt Adelman MD Self Board Member 000 0000
Clive Dix Ph.D Self Board Member 000 0000
Elaine Sullivan Ph.D Carrick Therapeutics Co-Founder, Chief Executive Officer & Board Member 000 0000
George Golumbeski Ph.D Self Chairman 000 0000
Jason Lettmann Lightstone Ventures Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »